These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9202537)
1. T1a and T1b breast cancer: a twelve-year experience. Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459 [TBL] [Abstract][Full Text] [Related]
3. Axillary lymph node dissection in breast cancer: an evolving question? Lagares-Garcia JA; Garguilo G; Kurek S; LeBlond G; Diaz F Am Surg; 2000 Jan; 66(1):66-72. PubMed ID: 10651351 [TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node status of T1 primary breast cancer in a diverse population. Madan AK; Macareo L; Winfrey K; Beech DJ Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902 [TBL] [Abstract][Full Text] [Related]
5. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
6. Predictors of axillary lymph node metastasis in T1 breast carcinoma. Shoup M; Malinzak L; Weisenberger J; Aranha GV Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085 [TBL] [Abstract][Full Text] [Related]
7. T1a breast carcinoma and the role of axillary dissection. Schneidereit NP; Davis N; Mackinnon M; Speers CH; Truong PT; Olivotto IA Arch Surg; 2003 Aug; 138(8):832-7. PubMed ID: 12912740 [TBL] [Abstract][Full Text] [Related]
8. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207 [TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309 [TBL] [Abstract][Full Text] [Related]
10. Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma. Markopoulos C; Kouskos E; Gogas H; Mandas D; Kakisis J; Gogas J Am Surg; 2000 Nov; 66(11):1011-3. PubMed ID: 11090007 [TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node dissection: does it have a role in primary breast cancer? Pack MS; Thomas RS Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194 [TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node metastasis in stage T1a breast cancer: a pathologic review of 82 patients. Whitten TM; Fraser HR; Christensen WN; Turk PS Am Surg; 1997 Feb; 63(2):144-9. PubMed ID: 9012428 [TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes. Orr RK; Col NF; Kuntz KM Surgery; 1999 Sep; 126(3):568-76. PubMed ID: 10486611 [TBL] [Abstract][Full Text] [Related]
14. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation. Reddy SG; Kiel KD Breast J; 2007; 13(1):12-8. PubMed ID: 17214788 [TBL] [Abstract][Full Text] [Related]
15. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
16. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience. Vitucci C; Tirelli C; Graziano F; Santoro E J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501 [TBL] [Abstract][Full Text] [Related]
18. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related]
19. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study. Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895 [TBL] [Abstract][Full Text] [Related]
20. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]